Will Royal Bank of Scotland Group plc Overstretch Itself Again?

Is Royal Bank of Scotland Group plc (LON: RBS) now safe against toxic assets?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

rbsWhen the UK’s banks were hit by liquidity problems, Royal Bank of Scotland (LSE: RBS) (NYSE: RBS.US) led the way in spectacular fashion.

Retail banking consists of taking in deposits and lending money out, which is easy enough to grasp — but the quality of the loans a bank makes and the capital it has to back them up is key.

Crunch

And that’s what was woefully lacking when the crunch hit. Too many banks had made too many bad loans, bringing the phrase “toxic assets” into everyday usage, and RBS had paid too much money for expansion — for example, for its part in the acquisition of Dutch Bank ABN AMRO.

Since then, liquidity requirements on banks have been tightened, and the quantity and quality of a bank’s capital has come under close scrutiny — you’ll have heard talk of Tier 1 ratios and the like (with the word “Core” bandied around), so what’s that all about?

Capital vs risk

Well, Tier 1 capital represents the money a bank has to back up the risks it takes when it lends money, and the ratios measure that capital against the quantity and risk of a bank’s assets — assets like mortgages and business loans are risk-weighted by reducing their actual book value to compensate for the probability of some loans becoming unrecoverable. The exact definitions are controlled by the Basel Committee on Banking Supervision, and its Basel III rules.

So a bank’s Tier 1 ratio compares its Tier 1 capital with the risk-weighted value of its assets — with a Core Tier 1 ratio only including the best of the best of its capital, essentially just equity and retained profits.

Before the crisis, a Tier 1 ratio of only 4% minimum was required by banking regulations, with a Core Tier 1 minimum of only 2% needed.

But by 2018, banks will be required to show a Core Tier 1 ratio (or Common Equity Tier 1 ratio) of a minimum 7%, so how is RBS doing against that?

Getting stronger

Well, when the bank reported its results for the year ended December 2013, RBS reported Core Tier 1 capital of £42bn, with a Core ratio of 10.9%. In absolute terms, that’s a fall in capital from £47bn a year previously, but with progress made on non-performing assets, the ratio itself is up from 10.3%.

That doesn’t quite mean RBS is out of the woods yet, as definitions are being tightened and we should expect to see risk-weighting of assets becoming stricter.  But on an estimate for Basel III capital requirements, RBS reckons it has managed a tougher fully-loaded Common Equity Tier 1 ratio of 8.6%, which is up from 7.7% at the end of 2012.

Safe now?

Whether that means RBS is safe from future liquidity crunches, or whether the banking sector will just take longer and find different ways to overstretch itself, remains to be seen.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Alan does not own any shares in RBS.

More on Investing Articles

Investing Articles

Now 70p, is £1 the next stop for the Vodafone share price?

The Vodafone share price is back to 70p, but it's a long way short of the 97p it hit in…

Read more »

Concept of two young professional men looking at a screen in a technological data centre
Investing Articles

If I’d put £5,000 in Nvidia stock at the start of 2024, here’s what I’d have now

Nvidia stock was a massive winner in 2023 as the AI chipmaker’s profits surged across the year. How has it…

Read more »

Light bulb with growing tree.
Investing Articles

3 top investment trusts that ‘green’ up my Stocks and Shares ISA

I’ll be buying more of these investment trusts for my Stocks and Shares ISA given the sustainable and stable returns…

Read more »

Investing Articles

8.6% or 7.2%? Does the Legal & General or Aviva dividend look better?

The Aviva dividend tempts our writer. But so does the payout from Legal & General. Here he explains why he'd…

Read more »

a couple embrace in front of their new home
Investing Articles

Are Persimmon shares a bargain hiding in plain sight?

Persimmon shares have struggled in 2024, so far. But today's trading update suggests sentiment in the housing market's already improving.

Read more »

Market Movers

Here’s why the Unilever share price is soaring after Q1 earnings

Stephen Wright isn’t surprised to see the Unilever share price rising as the company’s Q1 results show it’s executing on…

Read more »

Investing Articles

Barclays’ share price jumps 5% on Q1 news. Will it soon be too late to buy?

The Barclays share price has been having a great time this year, as a solid Q1 gives it another boost.…

Read more »

Young black colleagues high-fiving each other at work
Investing Articles

The AstraZeneca share price lifts 5% on a top-and-bottom earnings beat

The AstraZeneca share price reached £120 today and helped push the FTSE 100 higher. Would I still buy this flying…

Read more »